These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28039570)

  • 1. Different transcriptional profiling between senescent and non-senescent human coronary artery endothelial cells (HCAECs) by Omeprazole and Lansoprazole treatment.
    Costarelli L; Giacconi R; Malavolta M; Basso A; Piacenza F; Provinciali M; Maggio MG; Corsonello A; Lattanzio F
    Biogerontology; 2017 Apr; 18(2):217-236. PubMed ID: 28039570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lysosomal enzyme activities by proton pump inhibitors.
    Liu W; Baker SS; Trinidad J; Burlingame AL; Baker RD; Forte JG; Virtuoso LP; Egilmez NK; Zhu L
    J Gastroenterol; 2013 Dec; 48(12):1343-52. PubMed ID: 23478938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
    Frelinger AL; Lee RD; Mulford DJ; Wu J; Nudurupati S; Nigam A; Brooks JK; Bhatt DL; Michelson AD
    J Am Coll Cardiol; 2012 Apr; 59(14):1304-11. PubMed ID: 22464259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Pump Inhibitors Accelerate Endothelial Senescence.
    Yepuri G; Sukhovershin R; Nazari-Shafti TZ; Petrascheck M; Ghebre YT; Cooke JP
    Circ Res; 2016 Jun; 118(12):e36-42. PubMed ID: 27166251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan.
    Kawai T; Kawakami K; Mikinori K; Takei K; Itoi T; Moriyasu F; Takagi Y; Aoki T; Watanebe K; Matsumoto Y; Rimbara E; Noguchi N; Sasatsu M
    Hepatogastroenterology; 2007 Mar; 54(74):649-54. PubMed ID: 17523342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IGFBP1 in the senescence of vascular endothelial cells and severity of aging‑related coronary atherosclerosis.
    Wu X; Zheng W; Jin P; Hu J; Zhou Q
    Int J Mol Med; 2019 Nov; 44(5):1921-1931. PubMed ID: 31545483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
    Clark DW; Strandell J
    Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors and vascular function: A prospective cross-over pilot study.
    Ghebremariam YT; Cooke JP; Khan F; Thakker RN; Chang P; Shah NH; Nead KT; Leeper NJ
    Vasc Med; 2015 Aug; 20(4):309-16. PubMed ID: 25835348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
    Zvyaga T; Chang SY; Chen C; Yang Z; Vuppugalla R; Hurley J; Thorndike D; Wagner A; Chimalakonda A; Rodrigues AD
    Drug Metab Dispos; 2012 Sep; 40(9):1698-711. PubMed ID: 22648560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin promotes endothelial-mesenchymal transition during stress-induced premature senescence through the activation of autophagy.
    Sasaki N; Itakura Y; Toyoda M
    Cell Commun Signal; 2020 Mar; 18(1):43. PubMed ID: 32164764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity.
    Hashioka S; Klegeris A; McGeer PL
    Exp Neurol; 2009 May; 217(1):177-83. PubMed ID: 19232345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells.
    Prattichizzo F; Giuliani A; Recchioni R; Bonafè M; Marcheselli F; De Carolis S; Campanati A; Giuliodori K; Rippo MR; Brugè F; Tiano L; Micucci C; Ceriello A; Offidani A; Procopio AD; Olivieri F
    Oncotarget; 2016 Mar; 7(11):11945-58. PubMed ID: 26943583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
    Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
    Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEF2A alters the proliferation, inflammation-related gene expression profiles and its silencing induces cellular senescence in human coronary endothelial cells.
    Xiong Y; Wang L; Jiang W; Pang L; Liu W; Li A; Zhong Y; Ou W; Liu B; Liu SM
    BMC Mol Biol; 2019 Mar; 20(1):8. PubMed ID: 30885136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan enhances mitochondrial activity and alters cellular functions in human coronary artery endothelial cells via AMP-activated protein kinase pathway.
    Kurokawa H; Sugiyama S; Nozaki T; Sugamura K; Toyama K; Matsubara J; Fujisue K; Ohba K; Maeda H; Konishi M; Akiyama E; Sumida H; Izumiya Y; Yasuda O; Kim-Mitsuyama S; Ogawa H
    Atherosclerosis; 2015 Apr; 239(2):375-85. PubMed ID: 25682036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells.
    Hwang HJ; Lee YR; Kang D; Lee HC; Seo HR; Ryu JK; Kim YN; Ko YG; Park HJ; Lee JS
    Cancer Lett; 2020 Oct; 490():100-110. PubMed ID: 32659248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescent endothelial cells: Potential modulators of immunosenescence and ageing.
    Pantsulaia Ia; Ciszewski WM; Niewiarowska J
    Ageing Res Rev; 2016 Aug; 29():13-25. PubMed ID: 27235855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
    Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis.
    Kromer W; Horbach S; Lühmann R
    Pharmacology; 1999 Aug; 59(2):57-77. PubMed ID: 10450061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.